Corneal ring segments proving their worth

Article

Ferrara corneal rings are a useful tool in the treatment of keratoconus but long-term stability still needs to be established.

Ferrara corneal rings are a useful tool in the treatment of keratoconus but long-term stability still needs to be established, according to Akef El Maghraby and colleagues from the Magrabi Eye and Ear Center, Jeddah, Saudi Arabia.

In a prospective, non-comparative study, 100 corneas with keratoconus were implanted with Ferrara intracorneal ring segments. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), spherical equivalent, cylinder power, topographic average K readings and cylinder were measured preoperatively and at one week, one, three, six and nine months postoperatively.

By the first month, all parameters had improved significantly and 92% maintained or improved their BCVA. No case required explantation and neither cone nor the depth of the segments affected the outcomes. Results were stable through the duration of follow-up.

The results suggest that intracorneal ring segments are effective but more long-term follow-up is required to establish stability.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.